What’s the Hidden Value in TEVA’s Stock?


This gallery contains 1 photo.

Last week I added Teva Pharmaceutical Industries (Symbol: TEVA) to my stock portfolio, at a price of $44.40. It’s not medtech, but it’s still within my chosen niche area of healthcare, and offers many of the traits I look for … Continue reading

9 Key Insights from an Angel Investor


This gallery contains 2 photos.

What do angel investors look for when considering investment opportunities? And what separates the success stories from the also-rans (or even crashes)? Recently I had the chance to discuss this with a successful angel investor and financier, Peter Mountford. Over … Continue reading

Lessons from Medtech?


Investing in publicly listed life science companies versus early stage growth companies involves dealing with very different animals. But can we learn lessons from companies in the public markets? Perhaps, by considering factors that such investors deem important we can … Continue reading